EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
The 78th World Health Assembly agrees to extend the Global Action Plan on the Public Health Response to Dementia
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
Celebrating 40 years of ADI
This year, 2024 marks the 40th year of Alzheimer's Disease International and our work to secure a future that includes greater awareness of the condition, increased access to care, post-diagnostic support,and emerging treatments as well as a achieving a world without stigma. ADI invites our global community to celebrate with us on this momentous occasion with thanks to all who have been with us on this journey over four decades.
ADI offers support to the EMA in assessing new Alzheimer’s disease therapies
The EMA regulates the availability of medicines across all 27 European Union Member States as well as Iceland, Norway, and Liechtenstein.
Countdown to the ADI Conference 2024: A message from our CEO and conference speakers
As we count down the remaining days until the launch of this global event in Kraków, Poland, ADI is proud to share a message from our CEO, Paola Barbarino, and highlight some of our key speakers joining us from 24-26 April 2024.
Advocating around the world in 31 Days: A round-up of global action in March 2024
From symposiums and conferences to high-level meetings and webinars, ADI delegates around the world have taken part in dynamic global efforts to improve the lives of those living with dementia and carers throughout the month of March.
Celebrating Global Excellence: Wicking Dementia Centre Receives ADI Accreditation
The Wicking Dementia Centre celebrates its achievement of gaining ADI Accreditation, becoming Australia's first educational provider to attain this award. This is a significant milestone in global dementia education and marks Wicking's dedication to excellence and its commitment to enhancing care standards worldwide.
Royals set to join ADI’s 36th International Conference
ADI is pleased to welcome both Her Majesty The Queen Sofía of Spain and Her Royal Highness Princess Muna Al Hussein of Jordan to ADI’s 36th International Conference
Expanding Dementia Research in Latin America: ADI at the ReD-Lat Annual Meeting in Buenos Aires
ADI’s Director of the Americas attends the ReD-Lat Annual Meeting in Buenos Aires, Argentina with the aim to strengthen the bonds between ADI's members and researchers attending ReD-Lat; fostering collaboration and knowledge exchange to advance the field of dementia research in Latin America and the Caribbean.
ADI attends the WHO Executive Board: A week of advocacy in Europe and beyond
As the global voice on dementia, ADI has embarked on impactful week of advocacy in Europe and beyond. Attending the WHO Executive Board meetings in Geneva, a high level meeting of health ministries at OECD, Paris, and virtually joining the HGPI in Japan. With key members of ADI staff making multiple addresses to international bodies seeking to improve and strengthen policies that relate to dementia.